您的当前位置:首页 > 行业数据 > 中国生物制药在COPD领域布局TSLP单抗、PDE3/4抑制剂等多款创新药物
图片属性
图片格式:PNG 图片大小:300KB 图片尺寸:2346*606
同报告图片
 / 4
中国生物制药在COPD领域布局TSLP单抗、PDE3/4抑制剂等多款创新药物_第1页
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
中国生物制药在COPD领域布局TSLP单抗、PDE3/4抑制剂等多款创新药物_第2页
中国生物制药在COPD领域布局TSLP单抗、PDE3/4抑制剂等多款创新药物_第3页
中国生物制药在COPD领域布局TSLP单抗、PDE3/4抑制剂等多款创新药物_第4页
fCDlm77ooag477ya5oWi6Zi76IK65oKj6ICF6IK657uE57uH5LiO5q2j5bi45Lq66IK657uE57uH5a+55q+UIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18Cnwg6aG555uuICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCDmlbDmja4gICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCDlgaXlurfnmoTogrrnu4Tnu4cgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCDmraPluLjmlK/msJTnrqEgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCDmhaLpmLvogrrnmoTogrrnu4Tnu4cgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwg5oWi6Zi76IK655qE5pSv5rCU566hICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCDmraPluLjkurrogrrms6EgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IOaFoumYu+iCuueahOiCuuazoeaJqeW8oOiejeWQiOOAgeWKn+iDvee8uuWksSAgICAgICAgIHwKfCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCDotYTmlpnmnaXmupDvvJrkuK3lsbHluILkurrmsJHljLvpmaLvvIzlm73ph5Hor4HliLjnoJTnqbbmiYAgfCDotYTmlpnmnaXmupDvvJrkuK3lsbHluILkurrmsJHljLvpmaLvvIzlm73ph5Hor4HliLjnoJTnqbbmiYAgfA==
中国生物制药在COPD领域布局TSLP单抗、PDE3/4抑制剂等多款创新药物_第5页
所属报告: 医药行业慢阻肺专题深度:慢病蓝海疗法迭代国产新药BD潜力凸显-250729(30页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠